Is the loss of weight caused by the injection of Tilpotide/Mufenda due to the weakening of hunger?

Patients with Tirzepatide will notice a significant decrease in appetite during treatment, so they often wonder whether the main reason for their weight loss is "weakened hunger". From a pharmacological perspective, this feeling is indeed one of the important mechanisms by which tilpotide works. By activating GLP-1 and GIP receptors, tilpotide can delay gastric emptying and enhance satiety, making it easier for patients to feel satisfied after meals, thereby reducing the desire to eat additional food. This suppression of appetite is thought to be one of the key factors in weight loss.

However, the weight loss effect of tilpotide does not solely depend on “weakening of hunger.” In addition to appetite regulation, it also optimizes the body's energy metabolism by improving insulin sensitivity and reducing blood sugar fluctuations, making fat consumption more efficient. The study found that patients treated with tilpotide also had positive changes in basal metabolic rate and fat oxidation, meaning weight loss is not just the result of eating less but also involves improvements in how the body uses energy. Compared with weight loss caused by simple dieting, tilpotide-induced weight loss is more stable and has an outstanding effect in reducing visceral fat, which is particularly important for reducing the risk of cardiovascular disease.

Patients commonly report reduced meal intake and especially decreased interest in high-calorie foods after taking tilpotide. This is because the drug affects the reward mechanism of the central nervous system, thereby reducing food cravings. It is this dual effect—reducing food intake and optimizing energy expenditure—that gives Tilpotide its significant advantages in weight loss.

Although tilpotide makes it easier for patients to control their diet, a reasonable diet and moderate exercise are still the keys to long-term weight management. The decrease in appetite caused by the drug is only an auxiliary, and over-reliance may lead to insufficient nutritional intake. Therefore, clinically it is usually recommended that patients use it under the guidance of a doctor to avoid metabolic imbalance caused by rapid weight loss.

Reference materials:https://www.drugs.com/tirzepatide.html